Trial Profile
Clinical Trials Insight: 700019815
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2010
Price :
$35
*
At a glance
- Drugs ANEB 001 (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- Sponsors Vernalis
- 14 Sep 2007 Status change from planning to in progress.
- 15 Dec 2006 New trial record.